Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Lure of Late-Stage Device Investing

This article was originally published in Start Up

Executive Summary

In 2006, the number of late-stage private equity deals in the medical device sector is up significantly from 2005. At the IN3 East medtech conference in October, a lively panel of venture capital investors from Galen Partners, 3i, Matignon Technologies and OrbiMed Advisors discussed why this is so, and the risks, benefits and models for late-stage investing.
Advertisement

Related Content

Industry Perspective - The Medtech Industry: A Look Back at 2006
Biomet Deal Opens Door for PE Buyers
VCs Turn to Late-Stage Devices
Late-Stage Dealmaking Takes Off
VCs Turn to Late-Stage Devices
Matignon Launches Major New European Device Fund
Devices for a Diabetes Epidemic
Encore Medical Goes Private
Encore Medical Goes Private
Feeding the Beast: Steady M&A Diet Fuels VAlue for Big Device Firms

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT037396

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel